This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–65.TitulaerMJMcCrackenLGabilondoIArmangueTGlaserCIizukaT. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol2013;12:157–65.10.1016/S1474-4422(12)70310-1Search in Google Scholar
Peery HE, Day GS, Dunn S, Fritzler MJ, Pruss H, De Souza C, et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev 2012;11:863–72.PeeryHEDayGSDunnSFritzlerMJPrussHDe SouzaC. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev2012;11:863–72.10.1016/j.autrev.2012.03.001Search in Google Scholar
Nokura K, Yamamoto H, Okawara Y, Koga H, Osawa H, Sakai K. Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand 1997;95:367–73.NokuraKYamamotoHOkawaraYKogaHOsawaHSakaiK. Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand1997;95:367–73.10.1111/j.1600-0404.1997.tb00227.xSearch in Google Scholar
Okamura H, Oomori N, Uchitomi Y. An acutely confused 15-year-old girl. Lancet 1997;350:488.OkamuraHOomoriNUchitomiY. An acutely confused 15-year-old girl. Lancet1997;350:488.10.1016/S0140-6736(97)06208-9Search in Google Scholar
Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005;58:594–604.VitalianiRMasonWAncesBZwerdlingTJiangZDalmauJ. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol2005;58:594–604.10.1002/ana.20614224588116178029Search in Google Scholar
Wright S, Hacohen Y, Jacobson L, Agrawal S, Gupta R, Philip S, et al. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child 2015;100:521–6.WrightSHacohenYJacobsonLAgrawalSGuptaRPhilipS. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child2015;100:521–6.10.1136/archdischild-2014-306795445362225637141Search in Google Scholar
Hacohen Y, Wright S, Waters P, Agrawal S, Carr L, Cross H, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013;84:748–55.HacohenYWrightSWatersPAgrawalSCarrLCrossH. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry2013;84:748–55.10.1136/jnnp-2012-303807368625623175854Search in Google Scholar
Irani SR, Vincent A. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurology 2016;133:185–97.IraniSRVincentA. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurology2016;133:185–97.10.1016/B978-0-444-63432-0.00011-627112678Search in Google Scholar
Shin YW, Lee ST, Shin JW, Moon J, Lim JA, Byun JI, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 2013;265:75–81.ShinYWLeeSTShinJWMoonJLimJAByunJI. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol2013;265:75–81.10.1016/j.jneuroim.2013.10.00524176648Search in Google Scholar
Huda S, Wong SH, Pettingill P, O’Connell D, Vincent A, Steiger M. An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. J Neurol 2015;262:418–24.HudaSWongSHPettingillPO’ConnellDVincentASteigerM. An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. J Neurol2015;262:418–24.10.1007/s00415-014-7588-025428531Search in Google Scholar
Pellkofer HL, Kuempfel T, Jacobson L, Vincent A, Derfuss T. Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies. J Neurol Neurosurg Psychiatry 2010;81:1407–8.PellkoferHLKuempfelTJacobsonLVincentADerfussT. Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies. J Neurol Neurosurg Psychiatry2010;81:1407–8.10.1136/jnnp.2009.18649420667865Search in Google Scholar
Kahn I, Helman G, Vanderver A, Wells E. Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis. Journal of Child Neurology 2017;32:243–5.KahnIHelmanGVanderverAWellsE. Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis. Journal of Child Neurology2017;32:243–5.10.1177/088307381667555727872179Search in Google Scholar
Heine J, Ly LT, Lieker I, Slowinski T, Finke C, Pruss H, et al. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study. J Neurol 2016;263:2395–402.HeineJLyLTLiekerISlowinskiTFinkeCPrussH. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study. J Neurol2016;263:2395–402.10.1007/s00415-016-8277-y27604620Search in Google Scholar
Zhang Y, Liu G, Jiang MD, Li LP, Su YY. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China. Clin Neurophysiol 2017;128:1227–33.ZhangYLiuGJiangMDLiLPSuYY. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China. Clin Neurophysiol2017;128:1227–33.10.1016/j.clinph.2017.04.01528527387Search in Google Scholar
Veciana M, Becerra JL, Fossas P, Muriana D, Sansa G, Santamarina E, et al. EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis. Epilepsy Behav 2015;49:280–5.VecianaMBecerraJLFossasPMurianaDSansaGSantamarinaE. EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis. Epilepsy Behav2015;49:280–5.10.1016/j.yebeh.2015.04.03226071995Search in Google Scholar
Wang R, Guan HZ, Ren HT, Wang W, Hong Z, Zhou D. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis. Seizure 2015;29:137–42.WangRGuanHZRenHTWangWHongZZhouD. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis. Seizure2015;29:137–42.10.1016/j.seizure.2015.04.00526076857Search in Google Scholar
Gabilondo I, Saiz A, Galan L, Gonzalez V, Jadraque R, Sabater L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011;77:996–9.GabilondoISaizAGalanLGonzalezVJadraqueRSabaterL. Analysis of relapses in anti-NMDAR encephalitis. Neurology2011;77:996–9.10.1212/WNL.0b013e31822cfc6b21865579Search in Google Scholar
Jones KC, Schwartz AC, Hermida AP, Kahn DA. A case of anti-NMDA receptor encephalitis treated with ECT. J Psychiatr Pract 2015;21:374–80.JonesKCSchwartzACHermidaAPKahnDA. A case of anti-NMDA receptor encephalitis treated with ECT. J Psychiatr Pract2015;21:374–80.10.1097/PRA.000000000000010026348805Search in Google Scholar
Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 2011;168:245–51.ChapmanMRVauseHE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry2011;168:245–51.10.1176/appi.ajp.2010.1002018121368306Search in Google Scholar
Braakman HM, Moers-Hornikx VM, Arts BM, Hupperts RM, Nicolai J. Pearls & Oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology 2010;75:e44-e46.BraakmanHMMoers-HornikxVMArtsBMHuppertsRMNicolaiJ. Pearls & Oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology2010;75:e44-e46.10.1212/WNL.0b013e3181f11dc120819992Search in Google Scholar
Matsumoto T, Matsumoto K, Kobayashi T, Kato S. Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis. Psychiatry Clin Neurosci 2012;66:242–3.MatsumotoTMatsumotoKKobayashiTKatoS. Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis. Psychiatry Clin Neurosci2012;66:242–3.10.1111/j.1440-1819.2012.02324.xSearch in Google Scholar
Jezequel J, Rogemond V, Pollak T, Lepleux M, Jacobson L, Grea H, et al. Cell- and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project. Biol Psychiatry 2017;82:766–72.JezequelJRogemondVPollakTLepleuxMJacobsonLGreaH. Cell- and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project. Biol Psychiatry2017;82:766–72.10.1016/j.biopsych.2017.06.015Search in Google Scholar
Gable M, Glaser C. Anti-N-methyl-D-aspartate receptor encephalitis appearing as a new-onset psychosis: Disease course in children and adolescents within the California encephalitis project. Pediatr Neurol 2017;72:25–30.GableMGlaserC. Anti-N-methyl-D-aspartate receptor encephalitis appearing as a new-onset psychosis: Disease course in children and adolescents within the California encephalitis project. Pediatr Neurol2017;72:25–30.10.1016/j.pediatrneurol.2017.01.023Search in Google Scholar
Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 2016;12:1–13.LancasterE. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol2016;12:1–13.10.3988/jcn.2016.12.1.1Search in Google Scholar
Lennox BR, Palmer-Cooper EC, Pollak T, Hainsworth J, Marks J, Jacobson L, et al. Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. Lancet Psychiatry 2017;4:42–8.LennoxBRPalmer-CooperECPollakTHainsworthJMarksJJacobsonL. Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. Lancet Psychiatry2017;4:42–8.10.1016/S2215-0366(16)30375-3Search in Google Scholar
Herken J, Pruss H. Red Flags: Clinical signs for identifying autoimmune encephalitis in psychiatric patients. Front Psychiatry 2017;8:25.HerkenJPrussH. Red Flags: Clinical signs for identifying autoimmune encephalitis in psychiatric patients. Front Psychiatry2017;8:25.10.3389/fpsyt.2017.00025531104128261116Search in Google Scholar
Maccaferri GE, Rossetti AO, Dalmau J, Berney A. Anti-N-methyl-D-aspartate receptor encephalitis: A new challenging entity for consultation-liaison psychiatrist. Brain Disord Ther 2016;5:215.MaccaferriGERossettiAODalmauJBerneyA. Anti-N-methyl-D-aspartate receptor encephalitis: A new challenging entity for consultation-liaison psychiatrist. Brain Disord Ther2016;5:215.Search in Google Scholar
Wright S, Hacohen Y, Jacobson L, Agrawal S, Gupta R, Philip S, et al. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dise Child 2015;100:521–6.WrightSHacohenYJacobsonLAgrawalSGuptaRPhilipS. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dise Child2015;100:521–6.10.1136/archdischild-2014-306795445362225637141Search in Google Scholar
McKeon GL, Robinson GA, Ryan AE, Blum S, Gillis D, Finke C, et al. Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review. J Clin Exp Neuropsychol 2017;6:1–19.McKeonGLRobinsonGARyanAEBlumSGillisDFinkeC. Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review. J Clin Exp Neuropsychol2017;6:1–19.Search in Google Scholar
